In this file
For someone considering Hims, the most useful starting point is this: Current branded and compounded pathways should be checked against the dated policy shift. A reassuring presentation does not answer that question on its own.
Our provider file follows the decision a patient faces—from identifying who offers care to understanding the next payment and the prescription label. This is a review of accessible documents, not a record of receiving treatment or a certification of the company’s clinicians and pharmacies.
Checkpoint 1 · Understand the service
Hims sits within Hims & Hers and separates its platform from the medical and pharmacy services described in its terms. The March 2026 company announcement changed its weight-loss strategy toward approved products, while describing limited compounding based on clinical need.
Write down the role of each organization involved. The site operator may collect information or payment, a separate practice may assess you, and another business may dispense the medicine. Ask Hims to identify those roles in your treatment documents.
Checkpoint 2 · Follow the money
The current documents distinguish Weight Loss Membership from a Medication Plan. We did not establish one current combined price for every product and pathway. Quotes copied from an older compounded-semaglutide campaign may not describe enrollment today.
The next useful comparison is a written invoice for the prescribed period. It should explain any membership, appointment, medicine, delivery, or testing charge that is required. Our Hims cost guide provides a way to organize the questions without guessing at missing amounts.
Checkpoint 3 · Identify the prescription
The strategic announcement is neither proof that compounding disappeared completely nor a promise that it is available on request. The treating professional should name the actual medicine and explain the medical reason for any proposed compounded preparation.
A familiar ingredient name is only part of a medication’s identity. The formulation, route, concentration, device, and the instructions supplied by the pharmacy also matter. Ask the prescriber why the exact preparation fits your needs and what approved options were considered.
Checkpoint 4 · Plan for a change
The August 31 terms say the first membership month is non-refundable and shipped medication is not refundable. Other medication cancellation and refund circumstances have their own timing rules. Read the membership clause and medication clause independently, then ask which applies to the pending charge.
If your needs change, you may have to make two requests: one about clinical care and another about a future payment or order. Use the Hims cancellation file to separate those requests. A pharmacy already preparing a prescription can be in a different position from a subscription that has not renewed.
Checkpoint 5 · Reach the right person
The published telephone number for Hims is (800) 368-0038.
An administrative support representative may be able to find an order or invoice. Medication suitability, side effects, and instructions need the treating clinician or dispensing pharmacist.
Find the current contact and account information in the support file. We publish those routes for reference; this publication cannot open, cancel, or change a provider account.
A useful question for the consultation
Is this quote for membership, medication, or both, and what product would a current clinician actually consider?
Take the response back to the actual prescription and agreement. If it answers a different product, an introductory period you do not qualify for, or a pharmacy that has not been assigned, ask for clarification. A patient should not have to infer important terms from several inconsistent advertisements.
What this review cannot establish
We have not inspected a dispensing facility, tested a private patient portal, measured clinical response times, or compared patient outcomes across these services. Public documentation can inform a decision, but it does not prove that every person receives the same care.
Compounded preparations do not have FDA approval. An approved drug also has risks and eligibility requirements. Read the treatment-safety file and bring questions about your own health history to a licensed clinician.
Source notes
Provider material describes the company’s own offer. Official medical references explain clinical and regulatory context; they do not endorse this publication or its commercial partner.
- Hims & Hers: March 9, 2026 weight-loss strategy announcement ↗Provider-published information · Checked September 22, 2026
- Hims: terms updated August 31, 2026 ↗Provider-published information · Checked September 22, 2026
- FDA: concerns with unapproved GLP-1 drugs ↗Regulatory / public agency · Checked September 22, 2026
- FDA: risks of compounded drugs ↗Regulatory / public agency · Checked September 22, 2026